Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Hansen

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Ultrastructural Pathology|July 29, 2000
Subcellular distribution of urokinase and urokinase receptor in human neutrophils determined by immunoelectron microscopyT L Pedersen, T Plesner, T Horn, et al.
Acta Medica Scandinavica|January 1, 1976
Sequential studies of lymphocytes, neutrophils and serum proteins during prednisone treatmentO Clemmensen, V Andersen, N E Hansen, et al.
Experimental Hematology|January 1, 1994
Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid culturesH E Johnsen, L Jensen, E Gaarsdal, et al.
Journal of Environmental Quality|May 29, 2007
Runoff water quality from turfgrass established using volume-based composted municipal biosolids applicationsN E Hansen, D M Vietor, C L Munster, et al.
Ugeskrift for Laeger|September 5, 1988
[Medical treatment of cancer--an elucidating report]P Dombernowsky, H H Hansen, N E Hansen, et al.
American Journal of Hematology|January 1, 1995
Unexpected hepatotoxicity after priming and treatment with molgramostim (rhGM-CSF) in acute myeloid leukemia during induction chemotherapyP B Hansen, H E Johnsen, J O Lund, et al.
Leukemia & Lymphoma|November 1, 1995
Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomasP B Hansen, H E Johnsen, E Ralfkiaer, et al.
Blood|March 15, 1992
The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuriaM Ploug, T Plesner, E Rønne, et al.
Ugeskrift for Laeger|January 1, 1997
[Medical treatment of cancer]Dombernowsky, H H Hansen, M Hansen, et al.
Acta Medica Scandinavica|January 1, 1982
Neutrophil and lymphocyte function in patients with diabetes mellitusN H Valerius, C Eff, N E Hansen, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Ultrastructural Pathology|July 29, 2000
Subcellular distribution of urokinase and urokinase receptor in human neutrophils determined by immunoelectron microscopyT L Pedersen, T Plesner, T Horn, et al.
Acta Medica Scandinavica|January 1, 1976
Sequential studies of lymphocytes, neutrophils and serum proteins during prednisone treatmentO Clemmensen, V Andersen, N E Hansen, et al.
Experimental Hematology|January 1, 1994
Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid culturesH E Johnsen, L Jensen, E Gaarsdal, et al.
Journal of Environmental Quality|May 29, 2007
Runoff water quality from turfgrass established using volume-based composted municipal biosolids applicationsN E Hansen, D M Vietor, C L Munster, et al.
Ugeskrift for Laeger|September 5, 1988
[Medical treatment of cancer--an elucidating report]P Dombernowsky, H H Hansen, N E Hansen, et al.
American Journal of Hematology|January 1, 1995
Unexpected hepatotoxicity after priming and treatment with molgramostim (rhGM-CSF) in acute myeloid leukemia during induction chemotherapyP B Hansen, H E Johnsen, J O Lund, et al.
Leukemia & Lymphoma|November 1, 1995
Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomasP B Hansen, H E Johnsen, E Ralfkiaer, et al.
Blood|March 15, 1992
The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuriaM Ploug, T Plesner, E Rønne, et al.
Ugeskrift for Laeger|January 1, 1997
[Medical treatment of cancer]Dombernowsky, H H Hansen, M Hansen, et al.
Acta Medica Scandinavica|January 1, 1982
Neutrophil and lymphocyte function in patients with diabetes mellitusN H Valerius, C Eff, N E Hansen, et al.
Pageof 11